Stacey Knobler
Neurology with Special Qualifications in Child Neurology · Reno, NVNPI 1073705273
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,570 of the $3,017 with a category attached, or 85.2%. It is spread thinly across 20 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,192 and has fallen 79.2% since, to $248 in 2022.
Across 140 payments — averaging $21.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$634
- UCB, Inc.$397
- Eisai Inc.$378
- Takeda Pharmaceuticals U.S.A., Inc.$329
- Greenwich Biosciences, Inc.$214
- Supernus Pharmaceuticals, Inc.$190
- plus $875 from 14 others
What the payments were for
- Travel & lodging$44815%
- Food & beverage$2,57085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $634 |
| UCB, Inc. | 31 | $397 |
| Eisai Inc. | 21 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $329 |
| Greenwich Biosciences, Inc. | 10 | $214 |
| Supernus Pharmaceuticals, Inc. | 12 | $190 |
| Tris Pharma Inc | 9 | $173 |
| SK Life Science, Inc. | 5 | $126 |
| Zogenix Inc. | 1 | $111 |
| Neurelis, Inc. | 5 | $109 |
| Aquestive Therapeutics, Inc. | 4 | $68 |
| PTC Therapeutics, Inc. | 3 | $56 |
| Jazz Pharmaceuticals Inc. | 2 | $40 |
| Upsher-smith Laboratories LLC | 2 | $38 |
| Biocodex, Inc. | 2 | $37 |
| AstraZeneca(2 entities) | 2 | $32 |
| Harmony Biosciences LLC | 1 | $24 |
| Sanofi | 1 | $23 |
| Novartis | 1 | $21 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fintepla$111
How this compares
Too few neurology with special qualifications in child neurology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Reno
- Gerardo RodriguezReno$11K
- Colin NguyenReno$4K
- Tiffani McDonoughReno$286
- Shanti ThirumalaiReno$226
- Devraj ChavdaLas Vegas$7K
- Mei JiangLas Vegas$4K
- Roshan RajaHenderson$4K
- Herbert EzughaHenderson$3K
- Rooman AhadLas Vegas$2K
- Monica ChaconHenderson$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.